Preliminary results of raltitrexed in Chinese patients with metastatic colorectal cancer: A prospective, multicenter, real-world study.

被引：0
|
作者：
Li, Jin
Qin, Shukui
Zhou, Ai-Ping
Zhang, Yanqiao
Yuan, Xianglin
Qin, Baoli
Zeng, Shan
Shen, Lin
Yuan, Ying
Zhu, Liangjun
Wang, Weibo
Zhang, Xianwen
Liang, Jun
Ye, Feng
Chen, Ping
Wang, Huaizhang
Yu, Zhengyan
Fang, Yong
Yue, Lu
Xiong, Jianping
机构：
[1] Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China
[2] Nanjing Univ Chinese Med, Jinling Hosp, Nanjing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R China
[4] Harbin Med Univ, Affiliated Canc Hosp, Harbin, Peoples R China
[5] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Wuhan, Peoples R China
[6] Liaoning Canc Hosp & Inst, Shenyang, Peoples R China
[7] Cent South Univ, Dept Oncol, Xiangya Hosp, Changsha, Peoples R China
[8] Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol, Beijing, Peoples R China
[9] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Med Oncol, Hangzhou, Peoples R China
[10] Jiangsu Canc Hosp, Nanjing, Peoples R China
[11] Shandong Shengli Hosp, Jinan, Peoples R China
[12] Subei Peoples Hosp, Yangzhou, Peoples R China
[13] Peking Univ, Int Hosp, Beijing, Peoples R China
[14] Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China
[15] Ningxia Med Univ, Gen Hosp, Yinchuan, Peoples R China
[16] Mudanjiang Canc Hosp, Mudanjiang, Peoples R China
[17] ZheJiang Univ, Sir Run Run Shaw Hosp, Internal Med Oncol, Sch Med, Hangzhou, Peoples R China
[18] Qingdao Univ, Med Coll, Affiliated Hosp, Dept Oncol, Qingdao, Peoples R China
[19] Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang, Jiangxi, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3591
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Vulnerable patients with metastatic colorectal cancer in a real-world setting: A multicenter retrospective study.
    Mitani, Seiichiro
    Kito, Yosuke
    Hino, Kaori
    Kawakami, Kentaro
    Izawa, Naoki
    Hanamura, Fumiyasu
    Yamamoto, Yoshiyuki
    Shoji, Hirokazu
    Komori, Azusa
    Boku, Shogen
    Tsuchihashi, Kenji
    Baba, Eishi
    Kato, Kyoko
    Nonagase, Yoshikane
    Matsumoto, Toshihiko
    Furuta, Mitsuhiro
    Kawakami, Hisato
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 114 - 114
  • [2] Real-world Safety and Efficacy of Raltitrexed in Patients With Metastatic Colorectal Cancer
    Batra, Atul
    Rigo, Rodrigo
    Hannouf, Malek B.
    Cheung, Winson Y.
    CLINICAL COLORECTAL CANCER, 2021, 20 (02) : E75 - E81
  • [3] Real-world experience of trifluridine/tipiracil in patients with metastatic colorectal cancer: A multicenter United Kingdom study.
    Stavraka, Chara
    Pouptsis, Athanasios
    Kabuubi, Paul
    Angelis, Vasileios
    Synowiec, Alicja
    Baxter, Mark
    Barrie, Ainsley
    Costa, Amparo Andres
    Nizam, Alia
    De Naurois, Julien
    Mikropoulos, Christos
    Hill, Mark
    Graham, Janet Shirley
    Harris, Victoria
    Bridgewater, John A.
    Ross, Paul J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [4] Fruquintinib in refractory metastatic colorectal cancer: a multicenter real-world study
    Xu, D.
    Zeng, S.
    Qiu, W.
    Wang, G.
    Qin, Z.
    Liu, Y.
    Zhou, S.
    Zhang, Z.
    Chang, W.
    Feng, Q.
    Xu, J.
    ESMO OPEN, 2024, 9 (11)
  • [5] The Real-World Practice of Fruquintinib for Chinese Patients with Metastatic Colorectal Cancer
    Song, Yan
    Qu, Tao
    Zhang, Honggang
    Sun, Yongkun
    Cui, Chengxu
    Chi, Yihebali
    Zhang, Wen
    Wang, Xingyuan
    Yang, Lin
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 6199 - 6205
  • [6] Effect of cancer cachexia on treatment toxicity in metastatic colorectal cancer patients: Results of a prospective multicenter study.
    Barret, Maximilien
    Dalban, Cecile
    Taieb, Julien
    Malka, David
    Mansourbakht, Touraj
    Latko, Ewa
    Antoun, Sami
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Efficacy, treatment modalities, and safety of regorafenib in Chinese metastatic colorectal cancer patients: A multiple centers real-world study.
    Jiang, Zhichao
    Sun, Yongkun
    Zhang, Wen
    Liu, Ning
    Qiu, Wensheng
    Jiang, Tao
    Li, Sheng
    Sun, Ning
    Li, Xiaoyou
    Zhu, Liangjun
    Liu, Zimin
    Zhou, Ai-Ping
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study
    Seiichiro Mitani
    Yosuke Kito
    Kaori Hino
    Kentaro Kawakami
    Naoki Izawa
    Fumiyasu Hanamura
    Yoshiyuki Yamamoto
    Hirokazu Shoji
    Azusa Komori
    Shogen Boku
    Kenji Tsuchihashi
    Kyoko Kato
    Yoshikane Nonagase
    Toshihiko Matsumoto
    Mitsuhiro Furuta
    Hisato Kawakami
    Targeted Oncology, 2023, 18 : 707 - 715
  • [9] Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study
    Mitani, Seiichiro
    Kito, Yosuke
    Hino, Kaori
    Kawakami, Kentaro
    Izawa, Naoki
    Hanamura, Fumiyasu
    Yamamoto, Yoshiyuki
    Shoji, Hirokazu
    Komori, Azusa
    Boku, Shogen
    Tsuchihashi, Kenji
    Kato, Kyoko
    Nonagase, Yoshikane
    Matsumoto, Toshihiko
    Furuta, Mitsuhiro
    Kawakami, Hisato
    TARGETED ONCOLOGY, 2023, 18 (05) : 707 - 715
  • [10] Real-World Results of Raltitrexed Combined with S-1 and Bevacizumab in Heavily Pretreated Metastatic Colorectal Cancer
    Liu, Xiu
    Ma, Xiaoting
    Ou, Kai
    Wang, Qi
    Gao, Lizhen
    Yang, Lin
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 277 - 289
12345